Maternal serum soluble fms-like tyrosine kinase-1-to-placental growth factor ratio distinguishes growth-restricted from non-growth-restricted small-for-gestational-age fetusesAJOG Global Reports at a Glance
BACKGROUND: Fetal growth restriction secondary to chronic placental insufficiency is a major cause of perinatal morbidity and mortality. A significant proportion of fetuses with fetal growth restriction are small for gestational age, defined as a birthweight of ≤10th percentile. However, not all sma...
Saved in:
Main Authors: | Prithi Rajiv, MD (Author), Thomas Cade, MD (Author), Jennifer Dean, MD (Author), Gabriel Davis Jones, MD (Author), Shaun P. Brennecke, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy-associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1-placental growth factor ratio in the early second trimesterAJOG Global Reports at a Glance
by: Tianhua Huang, PhD, et al.
Published: (2023) -
Differential effects of growth restriction and immaturity on predicted psychomotor development at 4 years of age in preterm infantsAJOG Global Reports at a Glance
by: Arne Jensen, MD, et al.
Published: (2024) -
The Role of Placental Homeobox Genes in Human Fetal Growth Restriction
by: Padma Murthi, et al.
Published: (2011) -
Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction
by: Satoshi Shinohara, et al.
Published: (2017) -
Perinatal Outcomes of Fetuses with Early Growth Restriction, Late Growth Restriction, Small for Gestational Age, and Adequate for Gestational Age
by: Quênya Antunes Silveira Inácio, et al.
Published: (2020)